Potassium Iodide Nanoparticles Enhance Radiotherapy against Breast Cancer by Exploiting the Sodium-Iodide Symporter
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Iodine has shown promise in enhancing radiotherapy. However, conventional iodine compounds show fast clearance and low retention inside cancer cells, limiting their application as a radiosensitizer. Herein, we synthesize poly(maleic anhydride-alt-1-octadecene) coated KI nanoparticles (PMAO-KI NPs) and evaluate their potential for enhancing radiotherapy. Owing to the polymer coating, the KI core of PMAO-KI NPs is not instantly dissolved in aqueous solutions but slowly degraded, allowing for controlled release of iodide (I–). I– is transported into cells via the sodium iodide symporter (NIS), which is upregulated in breast cancer cells. Our results show that PMAO-KI NPs can enhance radiation-induced production of reactive oxygen species such as hydroxyl radicals. When tested in vitro with MCF-7 cells, PMAO-KI NPs promote radiation-induced DNA double-strand breaks and lipid peroxidation, causing a drop in cancer cell viability and reproductivity. When tested in MCF-7 bearing mice, PMAO-KI NPs show significant radiosensitizing effects, leading to complete tumor eradication in 80% of the treated animals without inducing additional toxicity. Overall, our strategy exploits electrolyte nanoparticles to deliver iodide into cancer cells through NIS, thus promoting radiotherapy against breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In some studies, marked tumor regression or complete tumor responses were described in a subset of treated animals [13,17,62,67].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [62]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“X-ray irradiation was the most frequently reported modality [17,20,27,34,54], whereas megavoltage radiation and radionuclide-based approaches were less commonly used [20,24,61,62].”
From Nanoparticle-Mediated Radiosensitization in Breast Cancer: A Systematic Review of Preclinical Evidence and Translational Challenges (2026) · cites this paper as [62]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Monodisperse FePt Nanoparticles and Ferromagnetic FePt Nanocrystal Superlattices
Sun, S., Murray, C. B., Weller, D., Folks, L., & Moser, A. (2000) · Science · doi:10.1126/science.287.5460.1989 · Cited by 6,137
Cancer and Radiation Therapy: Current Advances and Future Directions
Baskar, R., Lee, K. A., Yeo, R., & Yeoh, K.-W. (2012) · International Journal of Medical Sciences · doi:10.7150/ijms.3635 · Cited by 2,880
Tumor targeting via EPR: Strategies to enhance patient responses
Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262
Gold Nanoparticles as Radiation Sensitizers in Cancer Therapy
Chithrani, D. B., Jelveh, S., Jalali, F., van Prooijen, M., Allen, C., Bristow, R. G., Hill, R. P., & Jaffray, D. A. (2010) · Radiation Research · doi:10.1667/rr1984.1 · Cited by 669
Oleylamine as Both Reducing Agent and Stabilizer in a Facile Synthesis of Magnetite Nanoparticles
Xu, Z., Shen, C., Hou, Y., Gao, H., & Sun, S. (2009) · Chemistry of Materials · doi:10.1021/cm802978z · Cited by 581
The mammary gland iodide transporter is expressed during lactation and in breast cancer
Tazebay, U. H., Wapnir, I. L., Levy, O., Dohan, O., Zuckier, L. S., Hua Zhao, Q., Fu Deng, H., Amenta, P. S., Fineberg, S., Pestell, R. G., et al. (2000) · Nature Medicine · doi:10.1038/78630 · Cited by 493
Platinum nanoparticles: a promising material for future cancer therapy?
Porcel, E., Liehn, S., Remita, H., Usami, N., Kobayashi, K., Furusawa, Y., Sech, C. L., & Lacombe, S. (2010) · Nanotechnology · doi:10.1088/0957-4484/21/8/085103 · Cited by 423
Nanoscale Radiotherapy with Hafnium Oxide Nanoparticles
Maggiorella, L., Barouch, G., Devaux, C., Pottier, A., Deutsch, E., Bourhis, J., Borghi, E., & Levy, L. (2012) · Future Oncology · doi:10.2217/fon.12.96 · Cited by 373
Nanoparticle contrast agents for computed tomography: a focus on micelles
Cormode, D. P., Naha, P. C., & Fayad, Z. A. (2014) · Contrast Media & Molecular Imaging · doi:10.1002/cmmi.1551 · Cited by 362
Schmitt, F.-J., Renger, G., Friedrich, T., Kreslavski, V. D., Zharmukhamedov, S. K., Los, D. A., Kuznetsov, V. V., & Allakhverdiev, S. I. (2014) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2014.02.005 · Cited by 312
Wapnir, I. L., van de Rijn, M., Nowels, K., Amenta, P. S., Walton, K., Montgomery, K., Greco, R. S., Dohán, O., & Carrasco, N. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021544 · Cited by 303
Lazar, V., Bidart, J.-M., Caillou, B., Mahé, C., Lacroix, L., Filetti, S., & Schlumberger, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.9.5996 · Cited by 298
Polymer‐Coated Nanoparticles: A Universal Tool for Biolabelling Experiments
Zhang, F., Lees, E., Amin, F., Rivera_Gil, P., Yang, F., Mulvaney, P., & Parak, W. J. (2011) · Small · doi:10.1002/smll.201100608 · Cited by 297
Recent advances in radiotherapy of breast cancer
Haussmann, J., Corradini, S., Nestle-Kraemling, C., Bölke, E., Njanang, F. J. D., Tamaskovics, B., Orth, K., Ruckhaeberle, E., Fehm, T., Mohrmann, S., et al. (2020) · Radiation Oncology · doi:10.1186/s13014-020-01501-x · Cited by 180
Enhancement of radiosensitization by metal-based nanoparticles in cancer radiation therapy.
Su, X., Liu, P., Wu, H., & Gu, N. (2014) · PubMed · doi:10.7497/j.issn.2095-3941.2014.02.003 · Cited by 167
Radiosensitization by gold nanoparticles: Will they ever make it to the clinic?
Cui, L., Her, S., Borst, G. R., Bristow, R. G., Jaffray, D. A., & Allen, C. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.07.007 · Cited by 164
The Sodium Iodide Symporter and Its Potential Role in Cancer Therapy
Spitzweg, C., Harrington, K. J., PINKE, L. A., Vile, R. G., & Morris, J. C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7641 · Cited by 162
Review: Biofunctionalized Quantum Dots in Biology and Medicine
Mazumder, S., Dey, R., Mitra, M. K., Mukherjee, S., & Das, G. C. (2009) · Journal of Nanomaterials · doi:10.1155/2009/815734 · Cited by 160
Waite, C. L., & Roth, C. M. (2012) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.v40.i1.20 · Cited by 156
Kogai, T., Schultz, J. J., Johnson, L. S., Huang, M., & Brent, G. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140217197 · Cited by 154
Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival
Poleszczuk, J., Luddy, K. A., Chen, L., Lee, J. K., Harrison, L. B., Czerniecki, B. J., Soliman, H. H., & Enderling, H. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0870-1 · Cited by 126
Radiosensitizers in cervical cancer. Cisplatin and beyond
Candelaria, M., Garcia-Arias, A., Cetina, L., & Dueñas‐González, A. (2006) · Radiation Oncology · doi:10.1186/1748-717x-1-15 · Cited by 110
Aptamer-functionalized nanoscale metal-organic frameworks for targeted photodynamic therapy
Meng, H., Hu, X., Kong, G., Yang, C., Fu, T., Li, Z., & Zhang, X. (2018) · Theranostics · doi:10.7150/thno.26768 · Cited by 84
Self-citationUptake and antiproliferative effect of molecular iodine in the MCF-7 breast cancer cell line
Arroyo-Helguera, O. E., Anguiano, B., Delgado, G., & Aceves, C. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01250 · Cited by 69
The Chemical Sensitization of Pseudomonas Species to Ionizing Radiation
Bridges, B. A. (1962) · Radiation Research · doi:10.2307/3571155 · Cited by 55
Arroyo-Helguera, O. E., Rojas, E., Delgado, G., & Aceves, C. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0125 · Cited by 52
Sensitization of Radio-resistant Bacteria to X-rays by lodoacetamide
Dean, C. J., & ALEXANDER, P. (1962) · Nature · doi:10.1038/1961324a0 · Cited by 45
Enhanced radiation damage caused by iodinated contrast agents during CT examination
Wang, L., Li, Q., Wang, X., Hao, G., Jie-Bao, Hu, S., & Hu, C. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.04.005 · Cited by 36
Rösner, H., Möller, W., Groebner, S., & Torremante, P. (2016) · Oncology Letters · doi:10.3892/ol.2016.4811 · Cited by 32
Will radioiodine be useful in treatment of breast cancer?
Daniels, G. H., & Haber, D. A. (2000) · Nature Medicine · doi:10.1038/78604 · Cited by 30
Harun‐Or‐Rashid, M., Asai, M., Sun, X., Hayashi, Y., Sakamoto, J., & Murata, Y. (2010) · Thyroid Research · doi:10.1186/1756-6614-3-3 · Cited by 19
Extravasation of iodinated contrast medium in cancer patients undergoing computed tomography
Silva, H. C. D. S., Bitencourt, A. G. V., & Chojniak, R. (2018) · Radiologia Brasileira · doi:10.1590/0100-3984.2017.0064 · Cited by 14
Obeid, L., Deman, P., Tessier, A., Balosso, J., Estève, F., & Adam, J. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.239 · Cited by 13
Radiotherapy for cancer using X-ray fluorescence emitted from iodine
Tamura, M., Ito, H., & Matsui, H. (2017) · Scientific Reports · doi:10.1038/srep43667 · Cited by 12
Zhang, Z., Beyer, S. J., & Jhiang, S. M. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0342 · Cited by 12
Research works printed but not linked: 1
- Dean, 1965, The Sensitization of Bacteria to X-Rays by Iodoacetamide and Some Related Compounds, Prog. Biochem. Pharmacol., 1
Cited by
Wu, X., Zhou, Z., Li, K., & Liu, S. (2024) · Advanced Science · doi:10.1002/advs.202308632 · Cited by 92
Self-citationXu, Q., Zhang, M., Huang, Q., Gao, S., Chu, S., Li, Q., Chen, W., Zhang, X., Zhang, T., Tang, B. Z., et al. (2025) · Advanced Materials · doi:10.1002/adma.202502898 · Cited by 69
Self-citationMa, X., Lin, N., Yang, Q., Liu, P., Ding, H., Xu, M., Ren, F., Shen, Z., Hu, K., Meng, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52278-6 · Cited by 44
“Recent studies suggested that clinical iodinated contrast agents increased radiation-induced cancer cell death 21 , and potassium iodide nanoparticles enhanced radiotherapy 22 .”
An iodide-containing covalent organic framework for enhanced radiotherapy
Zhou, L., Guan, Q., Zhou, W. D., Kan, J., & Dong, Y. (2023) · Chemical Science · doi:10.1039/d3sc00251a · Cited by 34
Yin, M., Yuan, Y., Huang, Y., Liu, X., Meng, F., Luo, L., Tian, S., & Liu, B. (2024) · ACS Nano · doi:10.1021/acsnano.3c12623 · Cited by 27
Metadata
- Authors
- Cline, B. L., Jiang, W., Lee, C., Cao, Z., Yang, X., Zhan, S., Chong, H., Zhang, T., Han, Z., Wu, X., Yao, L., Wang, H., Zhang, W., Li, Z., & Xie, J.
- Affiliations
- University of Georgia (US)
- University of North Carolina at Chapel Hill (US)
- Howard Hughes Medical Institute , , , ,
- Corresponding author
- Zhang, Weizhong
- Li, Zibo
- Xie, Jin
- ORCID
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-10-25
- Volume
- 15
- Issue
- 11
- Pages
- 17401-17411
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- PMC
- PMC9035482
- OpenAlex
- W3211084211
- Cited by
- 32
- References
- 35
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 10 · 2023: 2 · 2022: 3
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- ACS Nano (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA247769, R01CA257851)
- National Institute of Biomedical Imaging and Bioengineering (R01EB022596)
- Division of Materials Research (NSF1552617)
- Topics
- Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Keywords
- radiosensitizers, breast cancer, sodium iodide symporter, controlled release, reactive oxygen species, hydroxyl radicals, DNA double-strand breaks, lipid peroxidation, MCF-7 cells, tumor-bearing mice
- MeSH terms
- Sodium-Iodide Symporters, Animals, Iodides, Neoplasms, Potassium Iodide, Tretinoin, Cell Line, Tumor, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.